Extendicare (TSE:EXE) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says

Extendicare (TSE:EXEGet Free Report) had its target price lifted by analysts at Royal Bank of Canada from C$9.50 to C$11.00 in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 4.46% from the company’s previous close.

Separately, TD Securities lifted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a report on Thursday, November 14th.

Read Our Latest Analysis on Extendicare

Extendicare Price Performance

TSE EXE traded down C$0.01 on Thursday, reaching C$10.53. 99,403 shares of the company’s stock traded hands, compared to its average volume of 135,117. Extendicare has a 12 month low of C$6.63 and a 12 month high of C$10.64. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The stock has a 50-day simple moving average of C$9.47 and a 200 day simple moving average of C$8.31. The stock has a market cap of C$878.94 million, a PE ratio of 15.51 and a beta of 1.26.

About Extendicare

(Get Free Report)

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.

Featured Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.